| NCT06856577 | Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration | RECRUITING | PHASE3 | 2025-02-28 | 2030-03-25 | 2027-04-28 |
| NCT05536973 | Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA] | ACTIVE_NOT_RECRUITING | PHASE2 | 2022-08-23 | 2028-08 | 2024-08-26 |
| NCT04418427 | ADVM-022 Intravitreal Gene Therapy for DME | COMPLETED | PHASE2 | 2020-05-28 | 2023-06-14 | 2022-11-22 |
| NCT03748784 | ADVM-022 Intravitreal Gene Therapy for Wet AMD | COMPLETED | PHASE1 | 2018-11-14 | 2022-06-22 | 2022-06-22 |
| NCT02168686 | Safety Dose Finding Study of ADVM-043 Gene Therapy to Treat Alpha-1 Antitrypsin (A1AT) Deficiency | COMPLETED | PHASE1, PHASE2 | 2017-11-28 | 2019-08-29 | 2019-08-29 |
| NCT02840669 | A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich's Ataxia (CARFA Study) | COMPLETED | NA | 2016-07 | 2018-09 | 2018-06 |